Modifiable lifestyle risk factors are able to reduce dementia risk only in people with low genetic risk.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Brain structural alterations and clinical features of cognitive frailty in Japanese community-dwelling older adults: the Arao study (JPSC-AD)
Scientific Reports Open Access 17 May 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Licher, S. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0547-7 (2019).
Lourida, I. et al. J. Am. Med. Assoc. https://doi.org/10.1001/jama.2019.9879 (2019).
Lyall, D. M. et al. Neurology 92, e2691–e2698 (2019).
Dekhtyar, S. et al. Ann. Neurol. 86, 68–78 (2019).
Canevelli, M. et al. Front. Neurol. 8, 628 (2017).
Rogers, N. T., Steptoe, A. & Cadar, D. Sci. Rep. 7, 15746 (2017).
Wallace, L. M. K. et al. Lancet Neurol. 18, 177–184 (2019).
MacLullich, A. M., Beaglehole, A., Hall, R. J. & Meagher, D. J. Int. Rev. Psychiatry 21, 30–42 (2009).
Persico, I. et al. J. Am. Geriatr. Soc. 66, 2022–2030 (2018).
Adamis, D., Devaney, A., Shanahan, E., McCarthy, G. & Meagher, D. Age Ageing 44, 318–321 (2015).
Davis, D. H. et al. JAMA Psychiatry 74, 244–251 (2017).
Livingston, G. et al. Lancet 390, 2673–2734 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
In addition to academic and hospital appointments, K.R. is President and Chief Science Officer of DGI Clinical, which in the past 5 years has contracts with pharma and device manufacturers (Baxter, Baxalta, Biogen, Shire, Hollister, Nutricia, Roche, Otsuka) on individualized outcome measurement. In 2017, he attended an advisory board meeting with Lundbeck. Otherwise, any personal fees are for invited guest lectures, rounds and academic symposia, received directly from event organizers, for presentations on frailty. He is Associate Director of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian Institutes of Health Research (CAN-137794), with additional funding from the Alzheimer Society of Canada and several other charities, as well as from Pfizer Canada and Sanofi Canada (in Phase 1, 2014–2019). He receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research, and research support through grants from the Canadian Institutes of Health Research, the Canadian Frailty Network, the Nova Scotia Health Research Foundation, the Nova Scotia Health Authority Research Fund and the Fountain Family Innovation Fund of the QEII Health Science Centre Foundation.
Rights and permissions
About this article
Cite this article
Rockwood, K., Wallace, L.M.K. & Davis, D.H. Genetic predisposition and modifiable risks for late-life dementia. Nat Med 25, 1331–1332 (2019). https://doi.org/10.1038/s41591-019-0575-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-019-0575-3